Find by identifier
CAS number index
39,377 CAS Registry Numbers in numeric order. A number with several grades opens a comparison page, a single match opens the product.
| CAS number | Substance | Listings |
|---|---|---|
| 259793-96-9 | Favipiravir | 1 |
| 259809-24-0 | Edoxaban Impurity (Stage-III) | 1 |
| 259809-25-1 | 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid lithium salt | 1 |
| 259886-50-5 | Cucurbit[7]uril | 1 |
| 260057-56-5 | Des-Gln3-Carbetocin | 1 |
| 260273-82-3 | 3-(2-Chloroethyl)-9-hydroxy-2-methylpyrido[1,2-a]pyrimidin-4-one | 1 |
| 260359-57-7 | Bioallethrin | 1 |
| 260371-16-2 | 4-(4-Fluorobenzoyl)-3-hydroxymethylbenzonitrile | 1 |
| 260397-58-8 | Dihydroisotanshinone II | 1 |
| 260435-42-5 | Rizatriptan EP Impurity H | 1 |
| 261506-45-0 | Acyclovir Sodium Dihydrate | 1 |
| 261522-33-2 | Fmoc-dehydro-Ala-OH | 1 |
| 261723-30-2 | 3-Chloro-2-fluorobenzyl alcohol | 1 |
| 261764-92-5 | 2-Chloro-4-nitrobenzene-1,3-diamine | 1 |
| 261951-96-6 | 2-Bromo-5-(trifluoromethoxy)toluene | 1 |
| 261953-36-0 | 6-Iodo-1H-indazole | 1 |
| 262268-58-6 | (E)-3-(3-(Trifluoromethyl)phenyl)acrylaldehyde, 98% | 1 |
| 262297-13-2 | 1-Butyl-3-methylimidazolium hydrogen sulphate, ≥95% (HPLC) | 1 |
| 262368-25-2 | Nintedanib Acetamide | 1 |
| 262368-30-9 | Nintedanib Intermediate 1 | 1 |
| 262423-77-8 | 2,4-Dichloro-nicotinic acid | 1 |
| 262587-06-4 | 3-(Difluoromethoxy)phenylacetic acid | 1 |
| 262845-82-9 | Lacosamide EP Impurity D | 1 |
| 263366-81-0 | Clozapine EP Impurity B | 1 |
| 263711-79-1 | Quercetin-d3 | 1 |
| 264624-38-6 | 27-Deoxyactein | 1 |
| 265121-01-5 | Fosaprepitant Dimeglumine Dibenzylester Impurity | 1 |
| 265121-04-8 | Fosaprepitant Dimeglumine | 1 |
| 265651-89-6 | 17-Methoxycarbonyl Loteprednol | 1 |
| 265659-61-8 | 2-Methylpentyl Chloroformate | 1 |
| 265989-44-4 | para-Hydroxy Atorvastatin (Ca Salt) | 1 |
| 265989-46-6 | 2-Hydroxy Atorvastatin Calcium Salt | 1 |
| 266356-00-7 | L-Lysine Diethylamide Dihydrochloride | 1 |
| 266689-70-7 | 2-((1S,2R,5S)-6,6-Dimethylbicyclo[3.1.1]heptan-2-yl)ethanol | 1 |
| 267650-77-1 | Gestodene EP Impurity F | 1 |
| 267668-71-3 | (1R,4R)-Rel-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol Hydrochloride | 1 |
| 267878-61-5 | Leuprolide impurity 4 | 1 |
| 268214-51-3 | Coronalolide | 1 |
| 268214-52-4 | Coronalolic acid | 1 |
| 268221-76-7 | Cyclo(-Ala-Gln) | 1 |
| 268545-13-7 | ent-Moxifloxacin | 1 |
| 268557-49-9 | Diethyl 2 acetamido 2 2 4 octylphenyl 2 oxo ethyl malonate | 1 |
| 268557-51-3 | 1-Hydroxy Fingolimod Hydrochloride | 1 |
| 269055-04-1 | Etravirine Impurity 5 | 1 |
| 269055-15-4 | Etravirine | 1 |
| 269055-19-8 | 4-((6-Amino-5-chloro-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-Dimethylbenzonitrile | 1 |
| 269410-08-4 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1 |
| 270083-97-1 | Zinc orotate dihydrate | 1 |
| 270573-71-2 | Tiron Monohydrate | 1 |
| 271241-14-6 | Dimefluthrin | 1 |
| 272451-65-7 | Flubendiamide | 1 |
| 272778-12-8 | Ezetimibe Impurity 9 | 1 |
| 272788-00-8 | R-Venlafaxine Di-p-toluoyl-D-tartrate Salt | 1 |
| 273211-28-2 | Eletriptan Hydrobromide Monohydrate | 1 |
| 273724-21-3 | Thiamine Monophosphate Chloride Dihydrate | 1 |
| 274257-37-3 | Tributylmethylammonium Methyl Carbonate Solution ~50% In Methanol: Water (2:3) | 1 |
| 274263-65-9 | Levosimendan Cyanoacetamide Hydrazone Impurity | 1 |
| 274675-25-1 | Xanthohumol D | 1 |
| 274676-43-6 | Cyclohexyldimethylsilanol | 1 |
| 274693-26-4 | Ticagrelor EP Impurity D | 1 |
| 274693-27-5 | Ticagrelor | 1 |
| 274693-39-9 | Ticagrelor Sulfone | 1 |
| 274693-53-7 | Ticargrelor Intermediate C2 | 1 |
| 274693-54-8 | Ticagrelor Impurity 18 | 1 |
| 274693-55-9 | 1-Acetyladamantane Intermediate | 1 |
| 274901-16-5 | Vildagliptin WS | 1 |
| 275378-91-1 | (R)-1-(1-Hydroxy-3-phenylpropan-2-yl)urea | 1 |
| 276863-95-7 | Vilazodone Impurity-V (Int-C) | 1 |
| 277299-70-4 | 2-(3,4-Dimethylphenyl)-5-methyl-1H-pyrazol-3(2H)-one | 1 |
| 278783-22-5 | N-Nitroso Melatonin | 1 |
| 280110-69-2 | 1-Boc-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine | 1 |
| 280755-12-6 | Tulathromycin Impurity B | 1 |
| 280773-16-2 | Betrixaban 2-Nitro Impurity | 1 |
| 280773-17-3 | Betrixaban 2-Amino Impurity | 1 |
| 281660-34-2 | L-Alanyl-D-glutamine | 1 |
| 281664-76-4 | Profoxydim Lithium Salt | 1 |
| 282526-98-1 | Cetilistat | 1 |
| 283158-18-9 | 8-Hydroxyquinoline-5-sulfonic acid, monohydrate, 98% | 1 |
| 283159-90-0 | Valifenalate | 1 |
| 283173-50-2 | Rucaparib | 1 |
| 283173-80-8 | Rucaparib Impurity II | 1 |
| 283173-84-2 | Rucaparib Impurity 13 | 1 |
| 283584-52-1 | 5-Fluoro-1H-indole-2,3-dione 3-Hydrazone | 1 |
| 283594-90-1 | Spiromesifen | 1 |
| 284030-57-5 | Binimetinib Intermediate 3 | 1 |
| 284030-58-6 | Binimetinib Intermediate 4 | 2 |
| 284049-75-8 | 1-Butyl-3-methylimidazolium acetate, ≥96% (HPLC) | 2 |
| 284461-73-0 | Sorafenib | 1 |
| 284461-74-1 | N-Desmethyl Sorafenib | 1 |
| 284462-37-9 | Sorafenib EP Impurity A | 1 |
| 284474-43-7 | 3-Bromo-1-propanol-1,1,2,2,3,3-d6 | 1 |
| 284474-46-0 | 2-Iodoethanol-d4 | 1 |
| 284474-52-8 | 4-Hydroxybenzaldehyde-d4 | 1 |
| 284486-96-0 | Mexiletine HCl Impurities,KOE 5692 Cyclicl imine impurity | 1 |
| 284487-61-2 | 2-Picolinic-d4 Acid | 1 |
| 284487-65-6 | 2-Methylpentane-d14 | 1 |
| 284670-98-0 | Sorafenib Impurity E | 1 |
| 284677-66-3 | Enalaprilat EP Impurity G | 1 |
| 284686-27-7 | Nevirapine-12-(n-proylidenyl) | 1 |
| 285129-06-8 | 1,3,3-Trimethyl-2-(2-methylcyclopropyl)-1-cyclohexene | 1 |
| 285132-87-8 | Diethyl amine D10 Hydrochloride | 1 |
| 285143-14-8 | Flecainide N-acetyl | 1 |
| 285977-77-7 | Acetic Anhydride-13C4,d6 | 1 |
| 285977-83-5 | Thio Urea 13C,15N2 | 1 |
| 285979-69-3 | Choline-1,1,2,2-D4 bromide | 1 |
| 285979-79-5 | Equilin-d4 | 1 |
| 285979-80-8 | Sodium Estrone-d4 Sulfate | 1 |
| 285979-81-9 | Sodium Equilin-2,4,16,16-d4 Sulfate (stabilized with TRIS, 50% w/w) | 1 |
| 286367-62-2 | Sodium butyrate-2-13C | 1 |
| 286371-44-6 | 2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)aniline | 1 |
| 286425-32-9 | Sodium Trifluoroacetate-13C | 1 |
| 286930-02-7 | Fesoterodine | 1 |
| 286930-03-8 | Fesoterodine Fumarate | 1 |
| 286961-14-6 | N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester | 1 |
| 287100-67-8 | D-Glucose-1,6-13C2 | 1 |
| 287395-61-3 | Ibandronate EP Impurity A (Freebase) | 1 |
| 287399-24-0 | Acrylamide-13C | 1 |
| 287399-28-4 | 4-Hydroxybenzoic acid-13C7 | 1 |
| 287399-29-5 | Acetylsalicylic Acid EP Impurity A-13C6 | 1 |
| 287399-31-9 | Glyphosate-13C | 1 |
| 287471-30-1 | 1-Chloro-6,6-dimethylhept-2-en-4-yne | 1 |
| 287476-11-3 | Melamine-15N3 | 1 |
| 287477-53-6 | (S)-1-(3-Chlorophenyl)-2-Hydroxy-1-Propanone | 1 |
| 287714-41-4 | Rosuvastatin | 2 |
| 287930-71-6 | 5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine 4-methylbenzenesulfonate | 1 |
| 287930-73-8 | 4-Benzyl-2-hydroxymorpholin-3-one | 1 |
| 287930-75-0 | (2R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-4-(phenylmethyl)-3-morpholinone | 1 |
| 287930-77-2 | Montelukast (3S)-hydroxy propanol | 1 |
| 287935-37-9 | Ethyl 8-(2,4-dioxo-2H-benzo[e][1,3]oxazin-3(4H)-yl)octanoate | 1 |
| 287937-12-6 | Virodhamine | 1 |
| 287952-67-4 | 4-[4-(Trifluoromethoxy)phenoxy]piperidine | 1 |
| 287953-54-2 | N-Benzoyloxycarbonyl-4-piperidine sulfonyl chloride | 1 |
| 287980-84-1 | Nevirapine EP Impurity B | 1 |
| 287980-85-2 | Nevirapine EP Impurity C | 1 |
| 288325-76-8 | (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl (2R,5S)-5-chloro-1,3-oxathiolane-2-carboxylate | 1 |
| 288383-20-0 | Cediranib | 1 |
| 288584-78-1 | 13-Desethyl, 13-propyl-Erythromycin A | 1 |
| 289030-99-5 | Oleocanthal | 1 |
| 289042-10-0 | N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | 1 |
| 289042-11-1 | Methyl 4-(4-Fluorophenyl)-6-isopropyl-2-[N-methyl-N-(methylsulfonyl)amino]pyrimidine-5-carboxylate | 1 |
| 289042-12-2 | Rosuvastatin EP Impurity F | 1 |
| 289472-78-2 | (R)-Hydroxy Des(boric Acid) Bortezomib | 1 |
| 289472-80-6 | Bortezomib Impurity A | 1 |
| 289472-81-7 | Bortezomib Impurity G | 1 |
| 289480-64-4 | Treprostinil Sodium | 1 |
| 289499-45-2 | Canertinib Dihydrochloride | 1 |
| 289686-70-0 | 2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropanoic acid | 1 |
| 289698-61-9 | 3-Triisopropylsilyloxy-1-propyllithium | 1 |
| 289711-92-8 | Sucrose 1,6,6'-Tricarboxylate Trimethyl Ester | 1 |
| 289893-25-0 | Arimoclomol | 1 |
| 290295-98-6 | Amiodarone EP Impurity I | 1 |
| 290296-72-9 | N-Desmethyl Netupitant | 1 |
| 290297-26-6 | Netupitant | 1 |
| 290312-62-8 | H-Ala-Ala-Gln-OH | 1 |
| 290819-03-3 | 2-Heptyl Chloroformate | 1 |
| 291756-76-8 | Vinamidinium Hexaflurophophate | 1 |
| 291765-93-0 | 1,2-Phenylenediamine-d4 | 1 |
| 291775-59-2 | Ledipasvir N-Boc Azabicyclo Heptane Acid | 1 |
| 292055-71-1 | (S,S)-Dihydro Bupropion Hydrochloride | 1 |
| 292055-72-2 | Erythrohydro Bupropion | 1 |
| 292067-97-1 | 5-Chloro-6'-methyl-3-(4-(methylthio)phenyl)-2,3'-bipyridine | 1 |
| 292135-78-5 | Roflumilast N-oxide | 1 |
| 292138-59-1 | 2-Chloro-4-methyl-thiazole-5-sulfonyl chloride | 1 |
| 292140-86-4 | 1-Ethyl-2,3-Dimethylimidazolium Hexafluorophosphate 98% | 1 |
| 292621-45-5 | 4-Bromo-2-fluorobenzamide | 1 |
| 293311-01-0 | 4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium | 1 |
| 293324-65-9 | Cyclopropyl(indolin-1-yl)methanone | 1 |
| 294175-43-2 | 10-Oxo Naloxone | 1 |
| 294194-13-1 | Diethyl 2-(4-chlorophenyl)-4-hydroxy-4-methyl-6-oxocyclohexane-1,3-dicarboxylate | 1 |
| 294882-33-0 | N-Demethyl Trimebutine Hydrochloride | 1 |
| 295328-72-2 | Ramipril EP Impurity B | 1 |
| 295349-64-3 | 2-Morpholin-4-ylpyridine-4-carboxylic acid | 1 |
| 295357-66-3 | Lenalidomide Impurity-3 | 1 |
| 295357-72-1 | 2-(4-Nitro-1-oxoisoindolin-2-yl)pentanedioic Acid | 1 |
| 295366-48-2 | 2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)-N,N-dimethylacetamide | 1 |
| 295803-03-1 | Gynuramide II | 1 |
| 296254-18-7 | 3-Methyl-2-propyl-pentanoic acid | 1 |
| 296282-40-1 | Nonyl Deoctyl Fingolimod Hydrochloride | 1 |
| 296282-43-4 | 4'-Deoctyl 4'-(1-Hydroxyoctyl) Fingolimod | 1 |
| 296760-88-8 | N-Nitroso Terbinafine EP Impurity A | 1 |
| 297175-66-7 | Amoxicilloic Acid Dimer (Mixture of Diastereomers) | 1 |
| 298220-99-2 | Desloratadine EP Impurity A | 1 |
| 298680-25-8 | (E/Z)-Ensifentrine | 1 |
| 298680-38-3 | Ensifentrine Impurity 6 | 1 |
| 298680-39-4 | Ensifentrine Amine Impurity | 1 |
| 299157-54-3 | Biotinyl-GHK tripeptide | 1 |
| 299165-27-8 | Amino(4-tert-butylphenyl)acetic acid | 1 |
| 299165-46-1 | Amino(3-isopropoxyphenyl)acetic acid | 1 |
| 299167-68-3 | Amino(4-iodophenyl)acetic acid | 1 |
| 299168-94-8 | Amino(3-phenoxyphenyl)acetic acid | 1 |
| 299409-85-1 | Clarithromycin EP impurity B | 1 |
| 300543-56-0 | (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine | 1 |
| 300547-20-0 | 4-[2-Ethoxy-5-(1-piperazinylsulfonyl)benzoamido]-1-methyl-3-propyl-1H-pyrazole-5-carboxamide | 1 |
| 300827-87-6 | Desvenlafaxine Hydrochloride | 1 |
| 300843-36-1 | Hydralazine Hydrochloride EP Impurity A | 1 |
| 301206-84-8 | Tris(bathophenanthrolinedisulphonate)ruthenium(II) sodium salt solution | 2 |
| 301221-79-4 | tert-Butyl 4-(bromoacetyl)piperidine-1-carboxylate | 1 |
| 301359-05-7 | 5-(4-Nitrophenyl)-2-furaldehyde Azine | 1 |
| 301533-59-5 | Methyl 4-butyramido-3-methylbenzoate | 1 |
| 301646-59-3 | Potassium ((4-(tert-butyl)phenyl)sulfonyl)(6-chloro-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)amide | 1 |
| 301646-60-6 | N-(6-(2-(tert-Butoxy)ethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)-4-(tert-butyl)benzenesulfonamide | 1 |
| 301669-82-9 | Omeprazole 4-Desmethyl Impurity | 1 |
| 301690-25-5 | Polmacoxib Impurity 3 | 1 |
| 301692-76-2 | Polmacoxib | 1 |
| 301693-50-5 | Polmacoxib Impurity 1 | 1 |
| 301693-70-9 | Polmacoxib Impurity 2 | 1 |
| 301836-41-9 | SB 431542 hydrate ≥98% (HPLC), powder | 1 |
| 301849-46-7 | Selamectin EP Impurity D | 1 |
| 302776-68-7 | Uvinul A Plus | 1 |
| 302781-98-2 | Ezetimibe Desfluoro Impurity | 1 |
| 302912-05-6 | DL-1,4-Dithiothreitol-d10 | 1 |
| 302953-58-8 | Pomalidomide Impurity 17 | 1 |
| 302962-47-6 | Des-2-(Piperazin-1-yl) 2-Amino Dasatinib | 1 |
| 302962-49-8 | Dasatinib | 1 |
| 302964-01-8 | Dasatinib Boc-Ethyl Ester | 1 |
| 302964-02-9 | 2-(tert-Butoxycarbonylamino)thiazole-5-carboxylic acid | 1 |
| 302964-06-3 | Dasatinib BOC Intermediate | 1 |
| 302964-08-5 | Dasatinib Dichloro Impurity | 1 |
| 302964-24-5 | 2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide | 1 |
| 303014-90-6 | Ethinyl Estradiol Dimer Impurity 1 | 1 |
| 303014-91-7 | Ethinyl Estradiol Dimer Impurity 2 | 1 |
| 303082-20-4 | Diricinoleoyl Stearoyl Glycerol Impurity | 1 |
| 304462-60-0 | O-Desmethyl Ivabradine | 1 |
| 304464-97-9 | 8-Demethyl Ivabradine | 1 |
| 304642-94-2 | Xerophilusin G | 1 |
| 304655-78-5 | 3-Amino-1,2,4-triazole-5-carboxylic acid hydrate, 98% | 1 |
| 304675-49-8 | Dysprosium (III) Acetate | 1 |
| 304675-55-6 | Europium (III) Oxalate | 1 |
| 304675-64-7 | Scandium Acetate | 1 |
| 304675-69-2 | Yttrium Acetate | 1 |
| 304680-35-1 | 1-Hexyl-3-methylimidazolium iodide, ≥97% (HPLC) | 1 |
| 304680-36-2 | 1-Methyl-3-octylimidazolium hexafluorophosphate, ≥95% | 1 |
| 304695-78-1 | Ethylene-Diamine Tetra Acetic Acid Calcium Disodium Salt | 1 |
| 304858-65-9 | 2-Amino-4-bromobenzonitrile, 98% | 1 |
| 304874-06-4 | Methyl 1-[(2-Fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-3-carboximidate | 1 |
| 305379-00-4 | L-Ido Miglustat | 1 |
| 306279-95-8 | Levocarnitine - Impuriy B | 1 |
| 306296-67-3 | N-Allyloxycarbonyl-4-piperidone | 1 |
| 306776-79-4 | DOTAGA-tetra (t-Bu ester), >99% | 2 |
| 307297-39-8 | Epitalon | 1 |
| 307492-75-7 | 1-Ethyl-2,3-dimethylimidazolium tetrafluoroborate, 98% | 1 |
| 307531-95-9 | 1-(6-Methylpyridin-3-yl)-2-(4-(methylsulfinyl)phenyl)ethan-1-one | 1 |
| 307531-96-0 | 2-Methyl-5-(3-(4-(methylsulfonyl)phenyl)furan-2-yl)pyridine | 1 |
| 307974-61-4 | Azithromycin EP Impurity B | 1 |
| 308064-97-3 | Evening Primrose Oil | 1 |
| 308066-66-2 | Fructooligosaccharides | 1 |
| 308068-56-6 | {Industrial grade} Multiwalled carbon nanotubes, 88% [COOH Functionalized] (OD: 10-30 nm, ID: 5-10 nm, Length: 10-30 um) | 48 |
| 308080-99-1 | Molecular sieves, 3 A | 1 |
| 308123-60-6 | 18-Methoxycoronaridine | 1 |
| 308362-25-6 | Ridinilazole | 1 |
Or browse by name